JP Morgan Warns HYPE Could Bleed Share to SOL and XRP as ETF Flows Cool

HYPE's ETF-led momentum cooled at a critical moment

HYPE's flow tail has weakened. Hyperliquid ETFs led non-Bitcoin crypto funds in inflows during both May and June, but demand for Hyperliquid funds stalled in July and August as competition intensified. When passive demand cools, competition matters more, not later.

The scale gap makes the slowdown more important

The issue is not that HYPE lacked momentum. It did. The issue is what is now competing for the same pool of capital. Hyperliquid ETFs led non-Bitcoin crypto funds in inflows during both May and June, so the July-August slowdown is more noticeable against that strong start. JPMorgan's broader point is that HYPE now has to compete with larger, more established crypto wrappers and trading venues just as its own flow advantage fades.

JPMorgan flagged structural pressure, not an immediate break

JPMorgan did not forecast an immediate collapse. Instead, the bank pointed to a structural risk: if regulated U.S. perpetual-futures venues expand, liquidity can move away from offshore and decentralized platforms. Because HYPE's value is still closely tied to platform activity and perpetual-futures fees, flattening ETF demand makes that market-share risk more immediate.

Why SOL and XRP matter more as ETF options widen

The core risk is liquidity rerouting, not just attention

JPMorgan's mechanism is straightforward: if regulated U.S. venues expand, capital can move toward products with clearer oversight and investor protections regulated U.S. perpetual-futures venues could pull liquidity from offshore and decentralized platforms. That matters because HYPE still depends on exchange activity and fee generation, so any shift in where traders and institutions prefer to access crypto derivatives can affect demand.

SOL and XRP have larger potential ETF channels

The bigger threat is not only competition. It is cleaner capital channels. JPMorgan sees Solana ETFs potentially capturing $3 billion to $6 billion within 6 to 12 months, while XRP ETFs could attract $4 billion to $8 billion if the product pipeline opens. Those ranges are large enough to matter even before either chain posts major fundamental outperformance. In market-share terms, HYPE does not need to outgrow SOL or XRP directly; it risks being bypassed if compliant wrappers draw institutional and retail capital first.

Prediction markets add a second competitive front

This is now a two-front issue. Hyperliquid's Outcomes offering entered a market with established platforms and new competitors. JPMorgan warned that Hyperliquid faces stronger competition from both regulated trading venues and prediction-market platforms as inflows into HYPE exchange-traded funds stall. That weakens the argument that product expansion alone can offset cooling flows.

Why SOL and XRP rank ahead in this setup

This is less a claim that HYPE is structurally inferior in every way and more a point about optionality. SOL and XRP have visible ETF pathways after multiple firms already submitted applications for Solana and XRP ETFs. As JPMorgan mentioning XRP in the same breath as SOL for ETF flows is telling, Wall Street is already framing them as the next major ETF candidates. That gives them a near-term narrative and capital-allocation advantage if regulation turns more favorable.

What to watch over the next few weeks

The near-term catalyst is timing. Initial Solana and XRP ETF decisions were expected by the end of this month. That makes this a timing question as much as a valuation debate.

• Bull case for SOL/XRP flow: a regulatory turn unlocks cleaner demand and draws capital toward regulated wrappers.
• Bear case for HYPE: share loss accelerates if investors prefer regulated venues or stronger alternatives in prediction markets.
• Invalidation signal: HYPE regains inflow momentum and holds trading share despite the broader ETF slowdown.

Valuation leaves less room for narrative alone

The flow warning matters, but the deeper test is whether HYPE's valuation can be supported by usage.

At roughly $11.66B, HYPE already has to prove itself

At roughly $11.66B circulating market cap, HYPE is no longer in discovery mode. Further upside now depends on sustained growth in trading volume, protocol revenue, and network effects, not just headline demand. That is why a flat ETF backdrop matters: if passive inflows stay cold, the token has to justify its multiple through platform activity while ETF inflows stalled in July and August.

The bullish case is still credible, but narrower

Bulls still have a real argument. JPMorgan itself noted that Hyperliquid is consolidating its lead in on-chain derivatives even as weaker rivals see volumes fade. That does not prove HYPE is immune to the broader shift. But it does suggest some rival growth was incentivized, while Hyperliquid's position may be more durable than the recent flow data implies.

The scoreboard now is trading share and flow reversals